Clinical significance of neurological abnormalities in psychosis

Advances in Psychiatric Treatment

Volumn 15, Issue 6, 2009, Pages 419-427

  Picchioni, Marco M ^a,b   Dazzan, Paola ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST ANDREW S HOSPITAL   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

AKATHISIA; CLINICAL EXAMINATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HEREDITY; HUMAN; MENTAL HEALTH CARE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PARKINSONISM; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PSYCHOSIS; RATING SCALE; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 77949475228     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.107.004408     Document Type: Review

References (76)

1. Allin M, Matsumoto H, Santhouse AM, et al (2001) Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain; 124: 60-6.
2. Arango C, Bartko JJ, Gold JM, et al (1999) Prediction of neuropsychological performance by neurological signs in schizophrenia. American Journal of Psychiatry; 156: 1349-57.
3. Arango C, Kirkpatrick B, Buchanan RW (2000) Neurological signs and the hetero geneity of schizophrenia. American Journal of Psychiatry; 157: 560-5.
4. Bachmann S, Bottmer C, Schroder J (2005) Neurological soft signs in first-episode schizophrenia: a follow-up study. American Journal of Psychiatry; 162: 2337-43.
5. Barkus E, Stirling J, Hopkins R, et al (2006) The presence of neurological soft signs along the psychosis proneness continuum. Schizophrenia Bulletin; 32: 573-7.
6. Barnes TR (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry; 154: 672-6.
7. Boks MP, Liddle PF, Russo S, et al (2003) Influence of antipsychotic agents on neurological soft signs and dyskinesia in first episode psychosis. Psychiatry Research; 119: 167-70.
8. Boks MP, Liddle PF, Burgerhof JG, et al (2004) Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica; 110: 29-35.
9. Bombin I, Arango C, Buchanan RW (2005) Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophrenia Bulletin; 31: 962-77.
10. Borgwardt SJ, Radue EW, Gotz K, et al (2006) Radiological findings in individuals at high risk of psychosis. Journal of Neurology, Neurosurgery, and Psychiatry; 77: 229-33.
11. Buchanan RW, Heinrichs DW (1989) The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research; 27: 335-50.
12. Caligiuri MP, Lohr JB (1997) Instrumental motor predictors of neuroleptic-induced Parkinsonism in newly medicated schizophrenia patients. Journal of Neuropsychiatry and Clinical Neurosciences; 9: 562-7.
13. Cannon M, Walsh E, Hollis C, et al (2001) Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. British Journal of Psychiatry; 178: 420-6.
14. Cantor-Graae E, McNeil TF, Rickler KC, et al (1994) Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma? American Journal of Psychiatry; 151: 1194-9.
15. Cantor-Graae E, Ismail B, McNeil TF (2000) Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma? Acta Psychiatrica Scandinavica; 101: 142-7.
16. Carnahan RM, Lund BC, Perry PJ, et al (2006) Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatrica Scandinavica; 113: 135-41.
17. Casey DE (2006) Implications of the CATIE trial on treatment: extrapyramidal symptoms. CNS Spectrums; 11: 25-31.
18. Chen EY, Shapleske J, Luque R, et al (1995) The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Research; 56: 183-204.
19. Convit A, Volavka J, Czobor P, et al (1994) Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. American Journal of Psychiatry; 151: 49-56.
20. Crow TJ, Done DJ, Sacker A (1995) Childhood precursors of psychosis as clues to its evolutionary origins. European Archives of Psychiatry and Clinical Neuroscience; 245: 61-9.
21. Dazzan P, Murray RM (2002) Neurological soft signs in first-episode psychosis: a systematic review. British Journal of Psychiatry; 181 (suppl 43): s50-7.
22. Dazzan P, Morgan KD, Orr KG, et al (2004) The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain; 127: 143-53.
23. Dazzan P, Morgan KD, Orr KG, et al (2005) Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology; 30: 765-74.
24. Dazzan P, Lloyd T, Morgan KD, et al (2008) Neurological abnormalities and cognitive ability in first-episode psychosis. British Journal of Psychiatry; 193: 197-202.
25. Egan MF, Hyde TM, Bonomo JB, et al (2001) Relative risk of neurological signs in siblings of patients with schizophrenia. American Journal of Psychiatry; 158: 1827-34.
26. Emsley RA, Turner HJ, Oosthuizen PP, et al (2005) Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophrenia Research; 75: 35-44.
27. Erhart SM, Young AS, Marder SR, et al (2005) Clinical utility of magnetic resonance imaging radiographs for suspected organic syndromes in adult psychiatry. Journal of Clinical Psychiatry; 66: 968-73.
28. Galderisi S, Maj M, Mucci A, et al (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. American Journal of Psychiatry; 159: 983-90.
29. Gangadhar BN, Jayakumar PN, Venkatasubramanian G, et al (2006) Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry; 30: 910-3.
30. Gourion D, Goldberger C, Olie JP, et al (2004) Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophrenia Research; 67: 23-31.
31. Heinrichs DW, Buchanan RW (1988) Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry; 145: 11-8.
32. Ho BC, Mola C, Andreasen NC (2004) Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biological Psychiatry; 55: 1146-53.
33. Hollister LE, Shah NN (1996) Structural brain scanning in psychiatric patients: a further look. Journal of Clinical Psychiatry; 57: 241-4.
34. Ismail BT, Cantor-Graae E, Cardenal S, et al (1998) Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophrenia Research; 30: 229-38.
35. Ismail B, Cantor-Graae E, McNeil TF (2001) Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophrenia Bulletin; 27: 629-41.
36. Keshavan MS, Sanders RD, Sweeney JA, et al (2003) Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. American Journal of Psychiatry; 160: 1298-304.
37. Kraepelin E (1919) Dementia Praecox and Paraphrenia. Livingston.
38. Lawrie SM, Byrne M, Miller P, et al (2001) Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. British Journal of Psychiatry; 178: 524-30.
39. Lencer R, Eismann G, Kasten M, et al (2004) Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms. British Journal of Psychiatry; 185: 465-71.
40. Liddle PF (1987) The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry; 151: 145-51.
41. Lieberman JA, Stroup TS, McEvoy JP, et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine; 353: 1209-23.
42. McCreadie RG, Thara R, Padmavati R, et al (2002) Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Archives of General Psychiatry; 59: 332-6.
43. McCreadie RG, Srinivasan TN, Padmavati R, et al (2005) Extrapyramidal symptoms in unmedicated schizophrenia. Journal of Psychiatry Research; 39: 261-6.
44. McNeil TF, Cantor-Graae E (2000) Neuromotor markers of risk for schizophrenia. Australian and New Zealand Journal of Psychiatry; 34 (suppl): s86-90.
45. Miller DD, McEvoy JP, Davis SM, et al (2005) Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophrenia Research; 80: 33-43.
46. Mohr F, Hubmann W, Albus M, et al (2003) Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Research; 121: 21-30.
47. Mueller C, Rufer M, Moergeli H, et al (2006) Brain imaging in psychiatry - a study of 435 psychiatric in-patients at a university clinic. Acta Psychiatrica Scandinavica; 114: 91-100.
48. Nasrallah HA, Tippin J, McCalley-Whitters M (1983) Neurological soft signs in manic patients. A comparison with schizophrenic and control groups. Journal of Affective Disorders; 5: 45-50.
49. National Institute of Mental Health (1976) Abnormal Involuntary Movement Scale (AIMS). In ECDEU: Assessment Manual for Psychopharmacology (ed W Guy): pp 534-7. US Department of Health, Education, and Welfare.
50. Picchioni MM, Toulopoulou T, Landau S, et al (2006) Neurological abnormalities in schizophrenic twins. Biological Psychiatry; 59: 341-8.
51. Potvin S, Pampoulova T, Mancini-Marie A, et al (2006) Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. Journal of Neurology, Neurosurgery, and Psychiatry; 77: 796-8.
52. Prikryl R, Ceskova E, Kasparek T, et al (2006) Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. Journal of Psychiatry Research; 40: 141-6.
53. Rao H, Di X, Chan RC, et al (2008) A regulation role of the prefrontal cortex in the fist-edge-palm task: evidence from functional connectivity analysis. Neuroimage; 41: 1345-51.
54. Rossi A, De Cataldo S, Di Michele V, et al (1990) Neurological soft signs in schizophrenia. British Journal of Psychiatry; 157: 735-9.
55. Rubin P, Vorstrup S, Hemmingsen R, et al (1994) Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatrica Scandinavica; 90: 385-90.
56. Sachdev P, Brodaty H, Rose N, et al (1999) Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation. British Journal of Psychiatry; 175: 416-21.
57. Sanders RD, Schuepbach D, Goldstein G, et al (2004) Relationships between cognitive and neurological performance in neuroleptic-naive psychosis. Journal of Neuropsychiatry and Clinical Neurosciences; 16: 480-7.
58. Scheffer RE (2004) Abnormal neurological signs at the onset of psychosis. Schizophrenia Research; 70: 19-26.
59. Schroder J, Niethammer R, Geider FJ, et al (1991) Neurological soft signs in schizophrenia. Schizophrenia Research; 6: 25-30.
60. Schroder J, Wenz F, Schad LR, et al (1995) Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. British Journal of Psychiatry; 167: 197-201.
61. Schubert EW, McNeil TF (2004) Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. American Journal of Psychiatry; 161: 1030-7.
62. Schubert EW, McNeil TF (2005) Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis. American Journal of Psychiatry; 162: 758-66.
63. Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica; 212 (suppl): 11-19.
64. Smith RC, Kadewari RP, Rosenberger JR, et al (1999) Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests. Schizophrenia Bulletin; 25: 813-25.
65. Srinivasan TN, Thara R, Padmavathi R, et al (2001) Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients. Schizophrenia Research; 47: 69-75.
66. Tarbox SI, Pogue-Geile MF (2006) Spontaneous dyskinesia and familial liability to schizophrenia. Schizophrenia Research; 81: 125-37.
67. Tarsy D, Baldessarini RJ (2006) Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Movement Disorders; 21: 589-98.
68. Tosato S, Dazzan P (2005) The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry; 18: 285-8.
69. Venkatasubramanian G, Latha V, Gangadhar BN, et al (2003) Neurological soft signs in never-treated schizophrenia. Acta Psychiatrica Scandinavica; 108: 144-6.
70. Walterfang M, Velakoulis D (2005) Cortical release signs in psychiatry. Australian and New Zealand Journal of Psychiatry; 39: 317-27.
71. Weinberger DR, Wyatt RJ (1982) Cerebral ventricular size: a biological marker for sub-typing chronic schizophrenia. In Biological Markers in Psychiatry and Neurology (ed EE Usdin): pp 505-12. Pergamon Press.
72. Whitty P, Clarke M, Browne S, et al (2003) Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine; 33: 1479-84.
73. Whitty P, Clarke M, McTigue O, et al (2006) Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research; 86: 110-7.
74. Wojcik JD, Gelenberg AJ, LaBrie RA, et al (1980) Prevalence of tardive dyskinesia in an outpatient population. Comprehensive Psychiatry; 21: 370-80.
75. Wonodi I, Adami HM, Cassady SL, et al (2004) Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center. Journal of Clinical Psychopharmacology; 24: 592-8.
76. Yazici AH, Demir B, Yazici KM, et al (2002) Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophrenia Research; 58: 241-6.